nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—TYMS—Methotrexate—germ cell cancer	0.342	0.729	CbGbCtD
Capecitabine—CYP2C9—Ifosfamide—germ cell cancer	0.0857	0.183	CbGbCtD
Capecitabine—CYP2C9—Cisplatin—germ cell cancer	0.0417	0.0888	CbGbCtD
Capecitabine—CYP2C9—cardial valve—germ cell cancer	0.0165	0.126	CbGeAlD
Capecitabine—TYMP—endothelium—germ cell cancer	0.0056	0.0425	CbGeAlD
Capecitabine—TYMP—blood vessel—germ cell cancer	0.00516	0.0392	CbGeAlD
Capecitabine—DPYD—decidua—germ cell cancer	0.0041	0.0311	CbGeAlD
Capecitabine—CDA—decidua—germ cell cancer	0.00394	0.03	CbGeAlD
Capecitabine—DPYD—uterus—germ cell cancer	0.00358	0.0272	CbGeAlD
Capecitabine—CYP2C9—urine—germ cell cancer	0.00357	0.0271	CbGeAlD
Capecitabine—TYMP—trigeminal ganglion—germ cell cancer	0.00319	0.0242	CbGeAlD
Capecitabine—CES1—neck—germ cell cancer	0.00319	0.0242	CbGeAlD
Capecitabine—DPYD—adrenal gland—germ cell cancer	0.00314	0.0239	CbGeAlD
Capecitabine—DPYD—bone marrow—germ cell cancer	0.00304	0.0231	CbGeAlD
Capecitabine—CDA—adrenal gland—germ cell cancer	0.00302	0.023	CbGeAlD
Capecitabine—DPYD—female gonad—germ cell cancer	0.00293	0.0223	CbGeAlD
Capecitabine—CDA—bone marrow—germ cell cancer	0.00293	0.0222	CbGeAlD
Capecitabine—CDA—endocrine gland—germ cell cancer	0.00262	0.0199	CbGeAlD
Capecitabine—DPYD—testis—germ cell cancer	0.0026	0.0198	CbGeAlD
Capecitabine—CDA—testis—germ cell cancer	0.0025	0.019	CbGeAlD
Capecitabine—TYMS—Vinorelbine—Vinblastine—germ cell cancer	0.00249	0.35	CbGdCrCtD
Capecitabine—TYMS—Podofilox—Etoposide—germ cell cancer	0.00248	0.35	CbGdCrCtD
Capecitabine—TYMP—decidua—germ cell cancer	0.00237	0.018	CbGeAlD
Capecitabine—TYMS—telencephalon—germ cell cancer	0.00215	0.0163	CbGeAlD
Capecitabine—TYMS—Vincristine—Vinblastine—germ cell cancer	0.00213	0.3	CbGdCrCtD
Capecitabine—TYMP—uterus—germ cell cancer	0.00208	0.0158	CbGeAlD
Capecitabine—TYMS—skin of body—germ cell cancer	0.00205	0.0156	CbGeAlD
Capecitabine—TYMP—pituitary gland—germ cell cancer	0.00204	0.0155	CbGeAlD
Capecitabine—TYMP—medulla oblongata—germ cell cancer	0.00197	0.015	CbGeAlD
Capecitabine—DPYD—brain—germ cell cancer	0.00195	0.0148	CbGeAlD
Capecitabine—DPYD—lymph node—germ cell cancer	0.00188	0.0143	CbGeAlD
Capecitabine—TYMP—adrenal gland—germ cell cancer	0.00182	0.0138	CbGeAlD
Capecitabine—CDA—lymph node—germ cell cancer	0.00181	0.0138	CbGeAlD
Capecitabine—TYMP—midbrain—germ cell cancer	0.0018	0.0137	CbGeAlD
Capecitabine—TYMS—gonad—germ cell cancer	0.00179	0.0136	CbGeAlD
Capecitabine—TYMP—bone marrow—germ cell cancer	0.00176	0.0134	CbGeAlD
Capecitabine—TYMP—spinal cord—germ cell cancer	0.00175	0.0133	CbGeAlD
Capecitabine—TYMP—female gonad—germ cell cancer	0.0017	0.0129	CbGeAlD
Capecitabine—TYMP—endocrine gland—germ cell cancer	0.00158	0.012	CbGeAlD
Capecitabine—CES1—adrenal gland—germ cell cancer	0.00157	0.012	CbGeAlD
Capecitabine—TYMS—adrenal gland—germ cell cancer	0.00156	0.0119	CbGeAlD
Capecitabine—TYMP—head—germ cell cancer	0.00156	0.0119	CbGeAlD
Capecitabine—TYMS—midbrain—germ cell cancer	0.00154	0.0117	CbGeAlD
Capecitabine—TYMS—bone marrow—germ cell cancer	0.00151	0.0115	CbGeAlD
Capecitabine—TYMP—testis—germ cell cancer	0.00151	0.0114	CbGeAlD
Capecitabine—CES1—female gonad—germ cell cancer	0.00147	0.0111	CbGeAlD
Capecitabine—TYMS—female gonad—germ cell cancer	0.00146	0.0111	CbGeAlD
Capecitabine—TYMP—cerebellum—germ cell cancer	0.00139	0.0106	CbGeAlD
Capecitabine—CES1—endocrine gland—germ cell cancer	0.00136	0.0104	CbGeAlD
Capecitabine—TYMS—endocrine gland—germ cell cancer	0.00136	0.0103	CbGeAlD
Capecitabine—CES1—head—germ cell cancer	0.00135	0.0102	CbGeAlD
Capecitabine—TYMS—head—germ cell cancer	0.00134	0.0102	CbGeAlD
Capecitabine—CES1—testis—germ cell cancer	0.0013	0.00988	CbGeAlD
Capecitabine—TYMS—testis—germ cell cancer	0.00129	0.00982	CbGeAlD
Capecitabine—TYMS—cerebellum—germ cell cancer	0.00119	0.00907	CbGeAlD
Capecitabine—TYMP—brain—germ cell cancer	0.00113	0.00859	CbGeAlD
Capecitabine—TYMP—lymph node—germ cell cancer	0.00109	0.0083	CbGeAlD
Capecitabine—CES1—brain—germ cell cancer	0.000976	0.00741	CbGeAlD
Capecitabine—TYMS—brain—germ cell cancer	0.00097	0.00737	CbGeAlD
Capecitabine—CES1—lymph node—germ cell cancer	0.000943	0.00716	CbGeAlD
Capecitabine—TYMS—lymph node—germ cell cancer	0.000937	0.00712	CbGeAlD
Capecitabine—CYP2C9—endocrine gland—germ cell cancer	0.000592	0.0045	CbGeAlD
Capecitabine—Renal failure acute—Methotrexate—germ cell cancer	0.000296	0.000756	CcSEcCtD
Capecitabine—Flatulence—Cisplatin—germ cell cancer	0.000296	0.000755	CcSEcCtD
Capecitabine—Anorexia—Dactinomycin—germ cell cancer	0.000296	0.000754	CcSEcCtD
Capecitabine—Eye disorder—Etoposide—germ cell cancer	0.000295	0.000754	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000294	0.000751	CcSEcCtD
Capecitabine—Cardiac disorder—Etoposide—germ cell cancer	0.000293	0.000748	CcSEcCtD
Capecitabine—Flushing—Etoposide—germ cell cancer	0.000293	0.000748	CcSEcCtD
Capecitabine—Discomfort—Ifosfamide—germ cell cancer	0.000293	0.000748	CcSEcCtD
Capecitabine—Hypersensitivity—Vinblastine—germ cell cancer	0.00029	0.00074	CcSEcCtD
Capecitabine—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.00029	0.00074	CcSEcCtD
Capecitabine—Decreased appetite—Bleomycin—germ cell cancer	0.000289	0.000738	CcSEcCtD
Capecitabine—Muscle spasms—Cisplatin—germ cell cancer	0.000289	0.000737	CcSEcCtD
Capecitabine—Angiopathy—Etoposide—germ cell cancer	0.000287	0.000732	CcSEcCtD
Capecitabine—Confusional state—Ifosfamide—germ cell cancer	0.000287	0.000731	CcSEcCtD
Capecitabine—Immune system disorder—Etoposide—germ cell cancer	0.000285	0.000728	CcSEcCtD
Capecitabine—Mediastinal disorder—Etoposide—germ cell cancer	0.000285	0.000727	CcSEcCtD
Capecitabine—Pain—Bleomycin—germ cell cancer	0.000284	0.000726	CcSEcCtD
Capecitabine—Oedema—Ifosfamide—germ cell cancer	0.000284	0.000725	CcSEcCtD
Capecitabine—Chills—Etoposide—germ cell cancer	0.000284	0.000724	CcSEcCtD
Capecitabine—Vision blurred—Cisplatin—germ cell cancer	0.000283	0.000722	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000283	0.000721	CcSEcCtD
Capecitabine—Asthenia—Vinblastine—germ cell cancer	0.000283	0.000721	CcSEcCtD
Capecitabine—Infection—Ifosfamide—germ cell cancer	0.000282	0.000721	CcSEcCtD
Capecitabine—Tremor—Cisplatin—germ cell cancer	0.000281	0.000718	CcSEcCtD
Capecitabine—Alopecia—Etoposide—germ cell cancer	0.000279	0.000713	CcSEcCtD
Capecitabine—Lethargy—Methotrexate—germ cell cancer	0.000279	0.000712	CcSEcCtD
Capecitabine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000279	0.000712	CcSEcCtD
Capecitabine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000279	0.000711	CcSEcCtD
Capecitabine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000279	0.000711	CcSEcCtD
Capecitabine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000278	0.00071	CcSEcCtD
Capecitabine—Anaemia—Cisplatin—germ cell cancer	0.000278	0.000708	CcSEcCtD
Capecitabine—Skin disorder—Ifosfamide—germ cell cancer	0.000276	0.000705	CcSEcCtD
Capecitabine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000275	0.000701	CcSEcCtD
Capecitabine—Feeling abnormal—Bleomycin—germ cell cancer	0.000274	0.000699	CcSEcCtD
Capecitabine—Osteoarthritis—Methotrexate—germ cell cancer	0.000274	0.000698	CcSEcCtD
Capecitabine—Anorexia—Ifosfamide—germ cell cancer	0.000271	0.000691	CcSEcCtD
Capecitabine—Malaise—Cisplatin—germ cell cancer	0.000271	0.000691	CcSEcCtD
Capecitabine—Decreased appetite—Dactinomycin—germ cell cancer	0.00027	0.000688	CcSEcCtD
Capecitabine—Diarrhoea—Vinblastine—germ cell cancer	0.000269	0.000688	CcSEcCtD
Capecitabine—Dysgeusia—Etoposide—germ cell cancer	0.000269	0.000687	CcSEcCtD
Capecitabine—Leukopenia—Cisplatin—germ cell cancer	0.000269	0.000686	CcSEcCtD
Capecitabine—Fatigue—Dactinomycin—germ cell cancer	0.000267	0.000682	CcSEcCtD
Capecitabine—Back pain—Etoposide—germ cell cancer	0.000266	0.000679	CcSEcCtD
Capecitabine—Hypotension—Ifosfamide—germ cell cancer	0.000266	0.000678	CcSEcCtD
Capecitabine—Pain—Dactinomycin—germ cell cancer	0.000265	0.000677	CcSEcCtD
Capecitabine—Muscle spasms—Etoposide—germ cell cancer	0.000264	0.000675	CcSEcCtD
Capecitabine—Urticaria—Bleomycin—germ cell cancer	0.000264	0.000674	CcSEcCtD
Capecitabine—Body temperature increased—Bleomycin—germ cell cancer	0.000263	0.000671	CcSEcCtD
Capecitabine—Irritability—Methotrexate—germ cell cancer	0.000261	0.000666	CcSEcCtD
Capecitabine—Dizziness—Vinblastine—germ cell cancer	0.00026	0.000664	CcSEcCtD
Capecitabine—Mood swings—Methotrexate—germ cell cancer	0.000259	0.000661	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000259	0.000661	CcSEcCtD
Capecitabine—Ataxia—Methotrexate—germ cell cancer	0.000257	0.000656	CcSEcCtD
Capecitabine—Myalgia—Cisplatin—germ cell cancer	0.000256	0.000652	CcSEcCtD
Capecitabine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000256	0.000652	CcSEcCtD
Capecitabine—Paraesthesia—Ifosfamide—germ cell cancer	0.000255	0.000651	CcSEcCtD
Capecitabine—Ill-defined disorder—Etoposide—germ cell cancer	0.000255	0.000651	CcSEcCtD
Capecitabine—Anxiety—Cisplatin—germ cell cancer	0.000255	0.00065	CcSEcCtD
Capecitabine—Anaemia—Etoposide—germ cell cancer	0.000254	0.000649	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000254	0.000648	CcSEcCtD
Capecitabine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000254	0.000647	CcSEcCtD
Capecitabine—Dyspnoea—Ifosfamide—germ cell cancer	0.000253	0.000647	CcSEcCtD
Capecitabine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000253	0.000645	CcSEcCtD
Capecitabine—Discomfort—Cisplatin—germ cell cancer	0.000253	0.000644	CcSEcCtD
Capecitabine—Vomiting—Vinblastine—germ cell cancer	0.00025	0.000639	CcSEcCtD
Capecitabine—Malaise—Etoposide—germ cell cancer	0.000248	0.000633	CcSEcCtD
Capecitabine—Breast disorder—Methotrexate—germ cell cancer	0.000247	0.000631	CcSEcCtD
Capecitabine—Vertigo—Etoposide—germ cell cancer	0.000247	0.000631	CcSEcCtD
Capecitabine—Decreased appetite—Ifosfamide—germ cell cancer	0.000247	0.000631	CcSEcCtD
Capecitabine—Headache—Vinblastine—germ cell cancer	0.000247	0.00063	CcSEcCtD
Capecitabine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000246	0.000629	CcSEcCtD
Capecitabine—Leukopenia—Etoposide—germ cell cancer	0.000246	0.000628	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000245	0.000626	CcSEcCtD
Capecitabine—Abdominal pain—Dactinomycin—germ cell cancer	0.000245	0.000626	CcSEcCtD
Capecitabine—Body temperature increased—Dactinomycin—germ cell cancer	0.000245	0.000626	CcSEcCtD
Capecitabine—Fatigue—Ifosfamide—germ cell cancer	0.000245	0.000625	CcSEcCtD
Capecitabine—Oedema—Cisplatin—germ cell cancer	0.000245	0.000625	CcSEcCtD
Capecitabine—Hypersensitivity—Bleomycin—germ cell cancer	0.000245	0.000625	CcSEcCtD
Capecitabine—Infection—Cisplatin—germ cell cancer	0.000243	0.000621	CcSEcCtD
Capecitabine—Pain—Ifosfamide—germ cell cancer	0.000243	0.00062	CcSEcCtD
Capecitabine—Constipation—Ifosfamide—germ cell cancer	0.000243	0.00062	CcSEcCtD
Capecitabine—Loss of consciousness—Etoposide—germ cell cancer	0.000242	0.000617	CcSEcCtD
Capecitabine—Nervous system disorder—Cisplatin—germ cell cancer	0.00024	0.000613	CcSEcCtD
Capecitabine—Cough—Etoposide—germ cell cancer	0.00024	0.000613	CcSEcCtD
Capecitabine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00024	0.000612	CcSEcCtD
Capecitabine—Tachycardia—Cisplatin—germ cell cancer	0.000239	0.00061	CcSEcCtD
Capecitabine—Asthenia—Bleomycin—germ cell cancer	0.000239	0.000609	CcSEcCtD
Capecitabine—Skin disorder—Cisplatin—germ cell cancer	0.000238	0.000607	CcSEcCtD
Capecitabine—Hypertension—Etoposide—germ cell cancer	0.000238	0.000606	CcSEcCtD
Capecitabine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000237	0.000605	CcSEcCtD
Capecitabine—Asthma—Methotrexate—germ cell cancer	0.000236	0.000603	CcSEcCtD
Capecitabine—Pruritus—Bleomycin—germ cell cancer	0.000235	0.0006	CcSEcCtD
Capecitabine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000234	0.000598	CcSEcCtD
Capecitabine—Chest pain—Etoposide—germ cell cancer	0.000234	0.000598	CcSEcCtD
Capecitabine—Nausea—Vinblastine—germ cell cancer	0.000234	0.000597	CcSEcCtD
Capecitabine—Anorexia—Cisplatin—germ cell cancer	0.000234	0.000596	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000233	0.000593	CcSEcCtD
Capecitabine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000232	0.000593	CcSEcCtD
Capecitabine—Discomfort—Etoposide—germ cell cancer	0.000231	0.00059	CcSEcCtD
Capecitabine—Hypotension—Cisplatin—germ cell cancer	0.000229	0.000584	CcSEcCtD
Capecitabine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000229	0.000583	CcSEcCtD
Capecitabine—Abdominal discomfort—Methotrexate—germ cell cancer	0.000227	0.000578	CcSEcCtD
Capecitabine—Confusional state—Etoposide—germ cell cancer	0.000226	0.000578	CcSEcCtD
Capecitabine—Urticaria—Ifosfamide—germ cell cancer	0.000226	0.000576	CcSEcCtD
Capecitabine—Abdominal pain—Ifosfamide—germ cell cancer	0.000225	0.000573	CcSEcCtD
Capecitabine—Body temperature increased—Ifosfamide—germ cell cancer	0.000225	0.000573	CcSEcCtD
Capecitabine—Pancytopenia—Methotrexate—germ cell cancer	0.000225	0.000573	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000223	0.00057	CcSEcCtD
Capecitabine—Infection—Etoposide—germ cell cancer	0.000223	0.000569	CcSEcCtD
Capecitabine—Asthenia—Dactinomycin—germ cell cancer	0.000223	0.000568	CcSEcCtD
Capecitabine—Dysuria—Methotrexate—germ cell cancer	0.000221	0.000564	CcSEcCtD
Capecitabine—Neutropenia—Methotrexate—germ cell cancer	0.000221	0.000564	CcSEcCtD
Capecitabine—Paraesthesia—Cisplatin—germ cell cancer	0.00022	0.000561	CcSEcCtD
Capecitabine—Thrombocytopenia—Etoposide—germ cell cancer	0.00022	0.000561	CcSEcCtD
Capecitabine—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00022	0.000561	CcSEcCtD
Capecitabine—Tachycardia—Etoposide—germ cell cancer	0.000219	0.000559	CcSEcCtD
Capecitabine—Dyspnoea—Cisplatin—germ cell cancer	0.000218	0.000557	CcSEcCtD
Capecitabine—Skin disorder—Etoposide—germ cell cancer	0.000218	0.000556	CcSEcCtD
Capecitabine—Hyperhidrosis—Etoposide—germ cell cancer	0.000217	0.000554	CcSEcCtD
Capecitabine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000216	0.000551	CcSEcCtD
Capecitabine—Anorexia—Etoposide—germ cell cancer	0.000214	0.000546	CcSEcCtD
Capecitabine—Decreased appetite—Cisplatin—germ cell cancer	0.000213	0.000544	CcSEcCtD
Capecitabine—Diarrhoea—Dactinomycin—germ cell cancer	0.000212	0.000542	CcSEcCtD
Capecitabine—Pneumonia—Methotrexate—germ cell cancer	0.000212	0.000541	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000212	0.00054	CcSEcCtD
Capecitabine—Vomiting—Bleomycin—germ cell cancer	0.000211	0.00054	CcSEcCtD
Capecitabine—Infestation NOS—Methotrexate—germ cell cancer	0.000211	0.000538	CcSEcCtD
Capecitabine—Infestation—Methotrexate—germ cell cancer	0.000211	0.000538	CcSEcCtD
Capecitabine—Depression—Methotrexate—germ cell cancer	0.00021	0.000536	CcSEcCtD
Capecitabine—Hypotension—Etoposide—germ cell cancer	0.00021	0.000535	CcSEcCtD
Capecitabine—Rash—Bleomycin—germ cell cancer	0.00021	0.000535	CcSEcCtD
Capecitabine—Pain—Cisplatin—germ cell cancer	0.00021	0.000535	CcSEcCtD
Capecitabine—Dermatitis—Bleomycin—germ cell cancer	0.00021	0.000535	CcSEcCtD
Capecitabine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000209	0.000534	CcSEcCtD
Capecitabine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000209	0.000533	CcSEcCtD
Capecitabine—Renal failure—Methotrexate—germ cell cancer	0.000207	0.000529	CcSEcCtD
Capecitabine—Stomatitis—Methotrexate—germ cell cancer	0.000206	0.000524	CcSEcCtD
Capecitabine—Conjunctivitis—Methotrexate—germ cell cancer	0.000205	0.000523	CcSEcCtD
Capecitabine—Asthenia—Ifosfamide—germ cell cancer	0.000204	0.00052	CcSEcCtD
Capecitabine—Feeling abnormal—Cisplatin—germ cell cancer	0.000202	0.000515	CcSEcCtD
Capecitabine—Paraesthesia—Etoposide—germ cell cancer	0.000202	0.000514	CcSEcCtD
Capecitabine—Pruritus—Ifosfamide—germ cell cancer	0.000201	0.000513	CcSEcCtD
Capecitabine—Haematuria—Methotrexate—germ cell cancer	0.000201	0.000513	CcSEcCtD
Capecitabine—Dyspnoea—Etoposide—germ cell cancer	0.0002	0.000511	CcSEcCtD
Capecitabine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000199	0.000509	CcSEcCtD
Capecitabine—Epistaxis—Methotrexate—germ cell cancer	0.000199	0.000507	CcSEcCtD
Capecitabine—Nausea—Bleomycin—germ cell cancer	0.000198	0.000504	CcSEcCtD
Capecitabine—Vomiting—Dactinomycin—germ cell cancer	0.000197	0.000503	CcSEcCtD
Capecitabine—Agranulocytosis—Methotrexate—germ cell cancer	0.000197	0.000502	CcSEcCtD
Capecitabine—Rash—Dactinomycin—germ cell cancer	0.000196	0.000499	CcSEcCtD
Capecitabine—Decreased appetite—Etoposide—germ cell cancer	0.000195	0.000498	CcSEcCtD
Capecitabine—Diarrhoea—Ifosfamide—germ cell cancer	0.000194	0.000496	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000194	0.000495	CcSEcCtD
Capecitabine—Body temperature increased—Cisplatin—germ cell cancer	0.000194	0.000494	CcSEcCtD
Capecitabine—Fatigue—Etoposide—germ cell cancer	0.000194	0.000494	CcSEcCtD
Capecitabine—Constipation—Etoposide—germ cell cancer	0.000192	0.00049	CcSEcCtD
Capecitabine—Pain—Etoposide—germ cell cancer	0.000192	0.00049	CcSEcCtD
Capecitabine—Haemoglobin—Methotrexate—germ cell cancer	0.00019	0.000485	CcSEcCtD
Capecitabine—Hepatitis—Methotrexate—germ cell cancer	0.000189	0.000483	CcSEcCtD
Capecitabine—Haemorrhage—Methotrexate—germ cell cancer	0.000189	0.000483	CcSEcCtD
Capecitabine—Dizziness—Ifosfamide—germ cell cancer	0.000188	0.00048	CcSEcCtD
Capecitabine—Pharyngitis—Methotrexate—germ cell cancer	0.000188	0.000479	CcSEcCtD
Capecitabine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000187	0.000477	CcSEcCtD
Capecitabine—Urethral disorder—Methotrexate—germ cell cancer	0.000186	0.000473	CcSEcCtD
Capecitabine—Feeling abnormal—Etoposide—germ cell cancer	0.000185	0.000472	CcSEcCtD
Capecitabine—Nausea—Dactinomycin—germ cell cancer	0.000184	0.00047	CcSEcCtD
Capecitabine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000184	0.000468	CcSEcCtD
Capecitabine—Visual impairment—Methotrexate—germ cell cancer	0.000182	0.000465	CcSEcCtD
Capecitabine—Vomiting—Ifosfamide—germ cell cancer	0.000181	0.000461	CcSEcCtD
Capecitabine—Hypersensitivity—Cisplatin—germ cell cancer	0.000181	0.000461	CcSEcCtD
Capecitabine—Rash—Ifosfamide—germ cell cancer	0.000179	0.000457	CcSEcCtD
Capecitabine—Dermatitis—Ifosfamide—germ cell cancer	0.000179	0.000457	CcSEcCtD
Capecitabine—Erythema multiforme—Methotrexate—germ cell cancer	0.000179	0.000457	CcSEcCtD
Capecitabine—Urticaria—Etoposide—germ cell cancer	0.000178	0.000455	CcSEcCtD
Capecitabine—Body temperature increased—Etoposide—germ cell cancer	0.000177	0.000453	CcSEcCtD
Capecitabine—Abdominal pain—Etoposide—germ cell cancer	0.000177	0.000453	CcSEcCtD
Capecitabine—Eye disorder—Methotrexate—germ cell cancer	0.000177	0.000451	CcSEcCtD
Capecitabine—Tinnitus—Methotrexate—germ cell cancer	0.000176	0.00045	CcSEcCtD
Capecitabine—Asthenia—Cisplatin—germ cell cancer	0.000176	0.000449	CcSEcCtD
Capecitabine—Cardiac disorder—Methotrexate—germ cell cancer	0.000176	0.000448	CcSEcCtD
Capecitabine—Angiopathy—Methotrexate—germ cell cancer	0.000172	0.000438	CcSEcCtD
Capecitabine—Immune system disorder—Methotrexate—germ cell cancer	0.000171	0.000436	CcSEcCtD
Capecitabine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000171	0.000435	CcSEcCtD
Capecitabine—Chills—Methotrexate—germ cell cancer	0.00017	0.000433	CcSEcCtD
Capecitabine—Nausea—Ifosfamide—germ cell cancer	0.000169	0.000431	CcSEcCtD
Capecitabine—Diarrhoea—Cisplatin—germ cell cancer	0.000168	0.000428	CcSEcCtD
Capecitabine—Alopecia—Methotrexate—germ cell cancer	0.000167	0.000427	CcSEcCtD
Capecitabine—Mental disorder—Methotrexate—germ cell cancer	0.000166	0.000423	CcSEcCtD
Capecitabine—Hypersensitivity—Etoposide—germ cell cancer	0.000165	0.000422	CcSEcCtD
Capecitabine—Erythema—Methotrexate—germ cell cancer	0.000165	0.00042	CcSEcCtD
Capecitabine—Malnutrition—Methotrexate—germ cell cancer	0.000165	0.00042	CcSEcCtD
Capecitabine—Dysgeusia—Methotrexate—germ cell cancer	0.000161	0.000412	CcSEcCtD
Capecitabine—Asthenia—Etoposide—germ cell cancer	0.000161	0.000411	CcSEcCtD
Capecitabine—Back pain—Methotrexate—germ cell cancer	0.000159	0.000407	CcSEcCtD
Capecitabine—Pruritus—Etoposide—germ cell cancer	0.000159	0.000405	CcSEcCtD
Capecitabine—Vomiting—Cisplatin—germ cell cancer	0.000156	0.000398	CcSEcCtD
Capecitabine—Vision blurred—Methotrexate—germ cell cancer	0.000155	0.000396	CcSEcCtD
Capecitabine—Rash—Cisplatin—germ cell cancer	0.000155	0.000394	CcSEcCtD
Capecitabine—Dermatitis—Cisplatin—germ cell cancer	0.000154	0.000394	CcSEcCtD
Capecitabine—Diarrhoea—Etoposide—germ cell cancer	0.000154	0.000392	CcSEcCtD
Capecitabine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000153	0.00039	CcSEcCtD
Capecitabine—Anaemia—Methotrexate—germ cell cancer	0.000152	0.000389	CcSEcCtD
Capecitabine—Malaise—Methotrexate—germ cell cancer	0.000149	0.000379	CcSEcCtD
Capecitabine—Dizziness—Etoposide—germ cell cancer	0.000148	0.000379	CcSEcCtD
Capecitabine—Vertigo—Methotrexate—germ cell cancer	0.000148	0.000378	CcSEcCtD
Capecitabine—Leukopenia—Methotrexate—germ cell cancer	0.000147	0.000376	CcSEcCtD
Capecitabine—Nausea—Cisplatin—germ cell cancer	0.000146	0.000371	CcSEcCtD
Capecitabine—Cough—Methotrexate—germ cell cancer	0.000144	0.000367	CcSEcCtD
Capecitabine—Vomiting—Etoposide—germ cell cancer	0.000143	0.000364	CcSEcCtD
Capecitabine—Rash—Etoposide—germ cell cancer	0.000142	0.000361	CcSEcCtD
Capecitabine—Dermatitis—Etoposide—germ cell cancer	0.000141	0.000361	CcSEcCtD
Capecitabine—Headache—Etoposide—germ cell cancer	0.000141	0.000359	CcSEcCtD
Capecitabine—Myalgia—Methotrexate—germ cell cancer	0.00014	0.000358	CcSEcCtD
Capecitabine—Chest pain—Methotrexate—germ cell cancer	0.00014	0.000358	CcSEcCtD
Capecitabine—Arthralgia—Methotrexate—germ cell cancer	0.00014	0.000358	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000139	0.000355	CcSEcCtD
Capecitabine—Discomfort—Methotrexate—germ cell cancer	0.000139	0.000354	CcSEcCtD
Capecitabine—Confusional state—Methotrexate—germ cell cancer	0.000136	0.000346	CcSEcCtD
Capecitabine—Infection—Methotrexate—germ cell cancer	0.000134	0.000341	CcSEcCtD
Capecitabine—Nausea—Etoposide—germ cell cancer	0.000133	0.00034	CcSEcCtD
Capecitabine—Nervous system disorder—Methotrexate—germ cell cancer	0.000132	0.000337	CcSEcCtD
Capecitabine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000132	0.000336	CcSEcCtD
Capecitabine—Skin disorder—Methotrexate—germ cell cancer	0.000131	0.000333	CcSEcCtD
Capecitabine—Hyperhidrosis—Methotrexate—germ cell cancer	0.00013	0.000332	CcSEcCtD
Capecitabine—Anorexia—Methotrexate—germ cell cancer	0.000128	0.000327	CcSEcCtD
Capecitabine—Hypotension—Methotrexate—germ cell cancer	0.000126	0.000321	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000123	0.000313	CcSEcCtD
Capecitabine—Insomnia—Methotrexate—germ cell cancer	0.000122	0.00031	CcSEcCtD
Capecitabine—Paraesthesia—Methotrexate—germ cell cancer	0.000121	0.000308	CcSEcCtD
Capecitabine—Dyspnoea—Methotrexate—germ cell cancer	0.00012	0.000306	CcSEcCtD
Capecitabine—Dyspepsia—Methotrexate—germ cell cancer	0.000118	0.000302	CcSEcCtD
Capecitabine—Decreased appetite—Methotrexate—germ cell cancer	0.000117	0.000298	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000116	0.000296	CcSEcCtD
Capecitabine—Fatigue—Methotrexate—germ cell cancer	0.000116	0.000296	CcSEcCtD
Capecitabine—Pain—Methotrexate—germ cell cancer	0.000115	0.000293	CcSEcCtD
Capecitabine—Feeling abnormal—Methotrexate—germ cell cancer	0.000111	0.000283	CcSEcCtD
Capecitabine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00011	0.000281	CcSEcCtD
Capecitabine—Urticaria—Methotrexate—germ cell cancer	0.000107	0.000273	CcSEcCtD
Capecitabine—Abdominal pain—Methotrexate—germ cell cancer	0.000106	0.000271	CcSEcCtD
Capecitabine—Body temperature increased—Methotrexate—germ cell cancer	0.000106	0.000271	CcSEcCtD
Capecitabine—Hypersensitivity—Methotrexate—germ cell cancer	9.91e-05	0.000253	CcSEcCtD
Capecitabine—Asthenia—Methotrexate—germ cell cancer	9.65e-05	0.000246	CcSEcCtD
Capecitabine—Pruritus—Methotrexate—germ cell cancer	9.51e-05	0.000243	CcSEcCtD
Capecitabine—Diarrhoea—Methotrexate—germ cell cancer	9.2e-05	0.000235	CcSEcCtD
Capecitabine—Dizziness—Methotrexate—germ cell cancer	8.89e-05	0.000227	CcSEcCtD
Capecitabine—Vomiting—Methotrexate—germ cell cancer	8.55e-05	0.000218	CcSEcCtD
Capecitabine—Rash—Methotrexate—germ cell cancer	8.48e-05	0.000216	CcSEcCtD
Capecitabine—Dermatitis—Methotrexate—germ cell cancer	8.47e-05	0.000216	CcSEcCtD
Capecitabine—Headache—Methotrexate—germ cell cancer	8.42e-05	0.000215	CcSEcCtD
Capecitabine—Nausea—Methotrexate—germ cell cancer	7.99e-05	0.000204	CcSEcCtD
